Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms

Journal of Translational Medicine

Volumn 3, Issue , 2005, Pages

  Stroncek, David F ^a   Basil, Christopher ^a   Nagorsen, Dirk ^b   Deola, Sara ^a   Aricó, Eleonora ^a   Smith, Kina ^a   Wang, Ena ^a   Marincola, Francesco M ^a   Panelli, Monica C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoimmunity; Interferon; Macrophages

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; ALPHA2 INTERFERON; ALPHA2B INTERFERON; ALPHA4B INTERFERON; ALPHAC INTERFERON; ALPHAH2 INTERFERON; ALPHAJ1 INTERFERON; BETA INTERFERON; CD14 ANTIGEN; CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; GROWTH FACTOR; INTERFERON; INTERFERON INDUCED HEPATITIS C ASSOCIATED MICROTUBULAR AGGREGATION PROTEIN; LIPOPOLYSACCHARIDE; MICROTUBULE PROTEIN; MYXOVIRUS RESISTANCE 1 PROTEIN; MYXOVIRUS RESISTANCE 2 PROTEIN; MYXOVIRUS RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CLASSIFICATION; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOLECULAR PHYLOGENY; MONONUCLEAR CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTE; POLARIZATION; TUMOR REJECTION;

EID: 27344449935     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-3-24     Document Type: Article

References (71)

1. Banchereau J, Pascual V, Palucka AK: Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004, 20(5):539-50.
2. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6):711-23. 2003 Mar 17
3. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-5.
4. Nagorsen D, Deola S, Smith K, Wang E, Monsurro V, Zanovello P, Marincola FM, Panelli MC: Polarized monocyte response to cytokine stimulation. Genome Biology 2005, 6:R15.
5. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophage as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
6. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
7. Anderson KV: Toll signaling pathways in the innate immune response. Curr Opin Immunol 2000, 12:13-19.
8. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM: The dual role of IL-10. Trends Immunol 2002, 24:36-43.
9. Gordon S: Alternative activation of macrophages. Nature Reviews 2003, 3:23-35.
10. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: Thechemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-86.
11. Huang Q, Liu D, Majewski P, et al.: The plasticity of dendritic cell-responses to pathogens and their components. Science 2001, 294:870-875.
12. Wang E, Miller L, Ohnmacht GA, Liu E, Marincola FM: High fidelity mRNA amplification for gene profiling using cDNA microarrays. Nature Biotech 2000, 17:457-459.
13. Wang E, Marincola FM: Amplification of small quantities of mRNA for transcript analysis. In: Bowtell D, Sambrook J, eds. DNA arrays - A Molecular Cloning Manual. Cold Springs Harbor, NY: Cold Spring Harbor Laboratory Press; 2002:204-213.
14. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
15. Ross DT, Scherf U, Eisen MB, et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics 2000, 24:227-235.
16. Regad T, Chelbi-Alix MK: Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 2001, 20:7274-86.
17. Espert L, Rey C, Gonzalez L, Degols G, Chelbi-Alix MK, Mechti N, Gongora C: The exonuclease ISG20 is directly induced by synthetic dsRNA via NF-kappaB and IRF1 activation. Oncogene 2004, 23:4636-40.
18. Espert L, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N: ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem 2003, 278:16151-8.
19. Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K: Analysis on the association of human BLYS (BAFF, TNFSF 13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 2002, 3:424-9.
20. Surin B, Rouillard D, Bauvois B: Interactions between human monocytes and fibronectin are suppressed by interferons beta and gamma, but not alpha: correlation with Rho-paxillin signaling. Int J Mol Med 2002, 10:25-31.
21. Arnheiter H, Meier E: Mx proteins: antiviral proteins by chance or by necessity? New Biol 1990, 2:851-7.
22. Sharif MN, Tassiulas I, Hu Y, Mecklenbrauker I, Tarakhovsky A, Ivashkiv LB: IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J Immunol 2004, 172:6476-81.
23. Taylor MW, Grosse WM, Schaley JE, Sanda C, Wu X, Chien SC, Smith F, Wu TG, Stephens M, Ferris MW, McClintick JN, Jerome RE, Edenberg HJ: Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. J nterferon Cytokine Res 2004, 24:107-18.
24. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001, 14:778-809.
25. Zhang J, Das SC, Kotalik C, Pattnaik AK, Zhang L: The latent membrane protein I of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J Biol Chem 2004, 279:46335-42.
26. Gongora C, Tissot C, Cerdan C, Mechti N: The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28. J Interferon Cytokine Res 2000, 20:955-61.
27. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM: The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 2004, 101:7578-82.
28. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY: Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003, 4:177-86.
29. Brem R, Oraszlan-Szovik K, Foser S, Bohrmann B, Certa U: Inhibition of proliferation by I-8U in interferon-alpha-responsive and non-responsive cell lines. Cell Mol Life Sci 2003, 60:1235-48.
30. Liu H, Kang H, Liu R, Chen X, Zhao K: Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol Cell Biol 2002, 22:6471-9.
31. Kloetzel PM, Ossendorp F: Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 2004, 16:76-81.
32. Hendil KB, Khan S, Tanaka K: Simultaneous binding of PA28 and PA700activators to 20 S proteasomes. Biochem J 1998, 332:749-54.
33. Cheng YS, Patterson CE, Staeheli P: Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol Cell Biol 1991, 11:4717-25.
34. Chin KC, Cresswell P: Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 2001, 98:15125-30. Erratum in: Proc Natl Acad Sci U S A 2002;99:2460.
35. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR, Shekhtman EM, Tomei LD, Umansky SR, Kiefer MC: Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997, 272:16351-7.
36. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-21.
37. Lucarelli E, Kaplan DR, Thiele CJ: Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-gamma in human neuroblastoma cell lines. J Biol Chem 1995, 270:24725-31.
38. Kitamura A, Takahashi K, Okajima A, Kitamura N: Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur J Biochem 1994, 224:877-83.
39. de Veer MJ, Sim H, Whisstock JC, Devenish RJ, Ralph SJ: IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics 1998, 54:267-77.
40. Levy D, Larner A, Chaudhuri A, Babiss LE, Darnell JE Jr: Interferon-stimulated transcription isolation of an inducible gene andidentification of its regulatory region. Proc Natl Acad Sci U S A 1986, 83:8929-33.
41. Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C: Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 2003, 37:1180-8.
42. Tang JP, Gu YY, Shen N, Ye S, Qian J, Hua J, Chen XG, Chen SL, Bao CD, Wang Y, Zhang W: Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 2004, 84:1157-60. Chinese
43. Le Page C, Genin P, Baines MG, Hiscott J: Interferon activation and innate immunity. Rev Immunogenet 2000, 2:374-86.
44. Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A, Yi T, Williams BR, Borden EC: Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res 2003, 23:745-56.
45. Imaizumi T, Hatakeyama M, Yamashita K, Yoshida H, Ishikawa A, Taima K, Satoh K, Mori F, Wakabayashi K: Interferon-gamma induces retinoic acid-inducible gene-I in endothelial cells. Endothelium 2004, 11:169-73.
46. Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, Li L, de la Torre JC, Zhang DE: Role of ISG15 protease UBP43 (USP 18) in innate immunity to viral infection. Nat Med 2004, 10:1374-8.
47. Malakhova OA, Yan M, Malakhov MP, Yuan Y, Ritchie KJ, Kim KI, Peterson LF, Shuai K, Zhang DE: Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 2003, 17:455-60.
48. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S: Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004, 5:1061-8.
49. Williams BR: Signal transduction and transcriptional regulation of interferon-alpha-stimulated genes. J Interferon Res 1991, 11:207-13.
50. Tamguney G, Van Snick J, Fickenscher H: Autocrine stimulation of rhadinovirus-transformed T cells by the chemokine CCLI/I-309. Oncogene 2004, 23:8475-85.
51. Zabel BA, Silverio AM, Butcher EC: Chemokine-like receptor I expression and chemerin-directed chemotaxisdistinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 2005, 174:244-51.
52. Cell Migration Consortium http://wrpx00.bioch.virginia.edu/cellmigtest/cmcweb/resorcue/cmckb/ sci_molecule_list.html
53. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK: The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility. Science in press. 2005 Jan 6
54. Freund C, Kuhne R, Yang H, Park S, Reinherz EL, Wagner G: Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules. EMBO J 2002, 21:5985-95.
55. Mah SA, Moy GW, Swanson WJ, Vacquier VD: A perforin-like protein from a marine mollusk. Biochem Biophys Res Commun 2004, 316:468-75.
56. Spilsbury K, O'Mara MA, Wu WM, Rowe PB, Symonds G, Takayama Y: Isolation of a novel macrophage-specific gene by differential cDNA analysis. Blood 1995, 85:1620-9.
57. Medley QG, Kedersha N, O'Brien S, Tian Q, Schlossman SF, Streuli M, Anderson P: Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci U S A 1996, 93:685-689.
58. Anderson SK, Gallinger S, Roder J, Frey J, Young HA, Ortaldo, JR: A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A 1993, 90:542-6.
59. Kim WH, Lee BL, Jun SH, Song SY, Kleinman HK: Expression of 32/67-kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines. Br J Cancer 1998, 77:15-20.
60. Simmons DL: The role of ICAM expression in immunity and disease. Cancer Surv 1995, 24:141-55.
61. Zannettino AC, Buhring HJ, Niutta S, Watt SM, Benton MA, Simmons PJ: The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 1998, 92:2613-28.
62. Rozanov DV, Sikora S, Godzik A, Postnova TI, Golubkov V, Savinov A, Tomlinson S, Strongin AY: Non-proteolytic, receptor/ligand interactionsassociate cellular membrane type-I matrix metalloproteinase with the complement component CI q. J Biol Chem 2004, 279:50321-8.
63. Li AL, Li HY, Jin BF, Ye QN, Zhou T, Yu XD, Pan X, Man JH, He K, Yu M, Hum MR, Wang J, Yang SC, Shen BF, Zhang XM: A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem 2004, 279:49251-8.
64. Kawaguchi Y, Kato K, Tanaka M, Kanamori M, Nishiyama Y, Yamanashi Y: Conserved protein kinases encoded by herpesviruses and cellular proteinkinase cdc2 target the same phosphorylation site in eukaryotic elongation factor I delta. J Virol 2003, 77:2359-68.
65. Nilsson A, Carlberg U, Nygard O: Kinetic characterisation of the enzymatic activity of the eEF-2-specific Ca2(+)-and calmodulin-dependent protein kinase III purified from rabbit reticulocytes. Eur J Biochem 1991, 195:377-83.
66. Te-Chung Liu: Biochemical and Biophysical Research communication 2000, 274:811-816.
67. Parmar S, Platanias LC: Interferons: mechanisms of action and clinical applications. Curr Opin Oncol 2003, 15:431-439.
68. Brassard DL, Grace MJ, Bordens RW: Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol 2002, 71:565-81.
69. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY: Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003, 4:177-86.
70. Chill JH, Quadt SR, Levy R, Schreiber G, Anglister J: The human type I interferon receptor. NMR structure reveals the molecular basis of ligand binding. Structure (Camb) 2003, 11:791-802.
71. Roisman LC, Piehler J, Trosset JY, Scheraga HA, Schreiber G: Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking. Proc Natl Acad Sci U S A 2001, 98:13231-13236.